CEVA INC (CEVA) Fundamental Analysis & Valuation

NASDAQ:CEVA • US1572101053

Current stock price

28.87 USD
+4.23 (+17.17%)
At close:
29 USD
+0.13 (+0.45%)
After Hours:

This CEVA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. CEVA Profitability Analysis

1.1 Basic Checks

  • In the past year CEVA was profitable.
  • CEVA had a negative operating cash flow in the past year.
  • CEVA had negative earnings in 4 of the past 5 years.
  • In multiple years CEVA reported negative operating cash flow during the last 5 years.
CEVA Yearly Net Income VS EBIT VS OCF VS FCFCEVA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M 20M -20M

1.2 Ratios

  • With a Return On Assets value of -2.74%, CEVA is not doing good in the industry: 60.00% of the companies in the same industry are doing better.
  • CEVA has a Return On Equity (-3.16%) which is in line with its industry peers.
Industry RankSector Rank
ROA -2.74%
ROE -3.16%
ROIC N/A
ROA(3y)-3.16%
ROA(5y)-3.38%
ROE(3y)-3.65%
ROE(5y)-3.95%
ROIC(3y)N/A
ROIC(5y)N/A
CEVA Yearly ROA, ROE, ROICCEVA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 -5

1.3 Margins

  • CEVA has a better Gross Margin (87.08%) than 98.26% of its industry peers.
  • In the last couple of years the Gross Margin of CEVA has remained more or less at the same level.
  • The Profit Margin and Operating Margin are not available for CEVA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 87.08%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.89%
GM growth 5Y-0.51%
CEVA Yearly Profit, Operating, Gross MarginsCEVA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. CEVA Health Analysis

2.1 Basic Checks

  • CEVA does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, CEVA has more shares outstanding
  • CEVA has more shares outstanding than it did 5 years ago.
  • There is no outstanding debt for CEVA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CEVA Yearly Shares OutstandingCEVA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M
CEVA Yearly Total Debt VS Total AssetsCEVA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

2.2 Solvency

  • An Altman-Z score of 10.26 indicates that CEVA is not in any danger for bankruptcy at the moment.
  • CEVA has a Altman-Z score of 10.26. This is in the better half of the industry: CEVA outperforms 65.22% of its industry peers.
  • CEVA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 10.26
ROIC/WACCN/A
WACC12.11%
CEVA Yearly LT Debt VS Equity VS FCFCEVA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M

2.3 Liquidity

  • CEVA has a Current Ratio of 9.93. This indicates that CEVA is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Current ratio value of 9.93, CEVA belongs to the best of the industry, outperforming 89.57% of the companies in the same industry.
  • CEVA has a Quick Ratio of 9.93. This indicates that CEVA is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of CEVA (9.93) is better than 93.91% of its industry peers.
Industry RankSector Rank
Current Ratio 9.93
Quick Ratio 9.93
CEVA Yearly Current Assets VS Current LiabilitesCEVA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. CEVA Growth Analysis

3.1 Past

  • CEVA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 13.51%, which is quite good.
  • CEVA shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -6.57% yearly.
  • The Revenue has been growing slightly by 2.49% in the past year.
  • The Revenue has been growing slightly by 1.79% on average over the past years.
EPS 1Y (TTM)13.51%
EPS 3Y-18.99%
EPS 5Y-6.57%
EPS Q2Q%63.64%
Revenue 1Y (TTM)2.49%
Revenue growth 3Y-6.62%
Revenue growth 5Y1.79%
Sales Q2Q%7.08%

3.2 Future

  • Based on estimates for the next years, CEVA will show a very strong growth in Earnings Per Share. The EPS will grow by 33.74% on average per year.
  • CEVA is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.99% yearly.
EPS Next Y21.71%
EPS Next 2Y40.17%
EPS Next 3Y33.74%
EPS Next 5YN/A
Revenue Next Year10.46%
Revenue Next 2Y12.13%
Revenue Next 3Y11.99%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CEVA Yearly Revenue VS EstimatesCEVA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 50M 100M 150M
CEVA Yearly EPS VS EstimatesCEVA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.2 0.4 0.6 0.8 1

More info and screens

Find the best growth stocksShow best growing peers

2

4. CEVA Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 68.74, CEVA can be considered very expensive at the moment.
  • CEVA's Price/Earnings ratio is a bit cheaper when compared to the industry. CEVA is cheaper than 60.87% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 27.42, CEVA is valued quite expensively.
  • With a Price/Forward Earnings ratio of 56.48, CEVA can be considered very expensive at the moment.
  • CEVA's Price/Forward Earnings ratio is in line with the industry average.
  • When comparing the Price/Forward Earnings ratio of CEVA to the average of the S&P500 Index (22.24), we can say CEVA is valued expensively.
Industry RankSector Rank
PE 68.74
Fwd PE 56.48
CEVA Price Earnings VS Forward Price EarningsCEVA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CEVA Per share dataCEVA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • CEVA's earnings are expected to grow with 33.74% in the coming years. This may justify a more expensive valuation.
PEG (NY)3.17
PEG (5Y)N/A
EPS Next 2Y40.17%
EPS Next 3Y33.74%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CEVA Dividend Analysis

5.1 Amount

  • No dividends for CEVA!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CEVA Fundamentals: All Metrics, Ratios and Statistics

CEVA INC

NASDAQ:CEVA (4/24/2026, 8:26:33 PM)

After market: 29 +0.13 (+0.45%)

28.87

+4.23 (+17.17%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)02-17
Earnings (Next)05-11
Inst Owners92.15%
Inst Owner Change-0.03%
Ins Owners3.48%
Ins Owner Change14.58%
Market Cap801.14M
Revenue(TTM)109.60M
Net Income(TTM)-10.64M
Analysts84.62
Price Target30.89 (7%)
Short Float %6.94%
Short Ratio4.63
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.44%
Min EPS beat(2)-2.82%
Max EPS beat(2)3.7%
EPS beat(4)2
Avg EPS beat(4)4.22%
Min EPS beat(4)-15.97%
Max EPS beat(4)31.98%
EPS beat(8)4
Avg EPS beat(8)47.97%
EPS beat(12)5
Avg EPS beat(12)15.12%
EPS beat(16)8
Avg EPS beat(16)13.73%
Revenue beat(2)0
Avg Revenue beat(2)-1.2%
Min Revenue beat(2)-1.28%
Max Revenue beat(2)-1.12%
Revenue beat(4)0
Avg Revenue beat(4)-3.28%
Min Revenue beat(4)-9.83%
Max Revenue beat(4)-0.89%
Revenue beat(8)2
Avg Revenue beat(8)-0.3%
Revenue beat(12)2
Avg Revenue beat(12)-3.88%
Revenue beat(16)4
Avg Revenue beat(16)-5.42%
PT rev (1m)-7.1%
PT rev (3m)-3.55%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-83.8%
EPS NY rev (1m)-0.11%
EPS NY rev (3m)-21.88%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-9.44%
Revenue NY rev (1m)0.04%
Revenue NY rev (3m)-2.68%
Valuation
Industry RankSector Rank
PE 68.74
Fwd PE 56.48
P/S 7.31
P/FCF N/A
P/OCF N/A
P/B 2.38
P/tB 2.89
EV/EBITDA N/A
EPS(TTM)0.42
EY1.45%
EPS(NY)0.51
Fwd EY1.77%
FCF(TTM)-0.23
FCFYN/A
OCF(TTM)-0.12
OCFYN/A
SpS3.95
BVpS12.12
TBVpS9.99
PEG (NY)3.17
PEG (5Y)N/A
Graham Number10.7041 (-62.92%)
Profitability
Industry RankSector Rank
ROA -2.74%
ROE -3.16%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 87.08%
FCFM N/A
ROA(3y)-3.16%
ROA(5y)-3.38%
ROE(3y)-3.65%
ROE(5y)-3.95%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.89%
GM growth 5Y-0.51%
F-Score4
Asset Turnover0.28
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 68.42%
Cap/Sales 2.67%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 9.93
Quick Ratio 9.93
Altman-Z 10.26
F-Score4
WACC12.11%
ROIC/WACCN/A
Cap/Depr(3y)72.38%
Cap/Depr(5y)58.96%
Cap/Sales(3y)3.03%
Cap/Sales(5y)2.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)13.51%
EPS 3Y-18.99%
EPS 5Y-6.57%
EPS Q2Q%63.64%
EPS Next Y21.71%
EPS Next 2Y40.17%
EPS Next 3Y33.74%
EPS Next 5YN/A
Revenue 1Y (TTM)2.49%
Revenue growth 3Y-6.62%
Revenue growth 5Y1.79%
Sales Q2Q%7.08%
Revenue Next Year10.46%
Revenue Next 2Y12.13%
Revenue Next 3Y11.99%
Revenue Next 5YN/A
EBIT growth 1Y-50.38%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year87.39%
EBIT Next 3Y56.02%
EBIT Next 5YN/A
FCF growth 1Y-2548.52%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-196.69%
OCF growth 3YN/A
OCF growth 5YN/A

CEVA INC / CEVA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of CEVA INC (CEVA) stock?

ChartMill assigns a fundamental rating of 4 / 10 to CEVA.


What is the valuation status for CEVA stock?

ChartMill assigns a valuation rating of 2 / 10 to CEVA INC (CEVA). This can be considered as Overvalued.


What is the profitability of CEVA stock?

CEVA INC (CEVA) has a profitability rating of 2 / 10.


What is the financial health of CEVA INC (CEVA) stock?

The financial health rating of CEVA INC (CEVA) is 8 / 10.


Can you provide the expected EPS growth for CEVA stock?

The Earnings per Share (EPS) of CEVA INC (CEVA) is expected to grow by 21.71% in the next year.